Pages that link to "Q44265199"
Jump to navigation
Jump to search
The following pages link to Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes (Q44265199):
Displaying 50 items.
- Does accumulation of advanced glycation end products contribute to the aging phenotype? (Q24632710) (← links)
- AGE down-regulation of monocyte RAGE expression and its association with diabetic complications in type 1 diabetes (Q28250227) (← links)
- An invertebrate hyperglycemic model for the identification of anti-diabetic drugs (Q28477568) (← links)
- Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products (Q33186938) (← links)
- Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy (Q33772238) (← links)
- Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion (Q33789513) (← links)
- Serum carboxymethyllysine, an advanced glycation end product, and age-related macular degeneration: the Age, Gene/Environment Susceptibility-Reykjavik Study (Q34213760) (← links)
- Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes (Q34256592) (← links)
- KIOM-79 protects AGE-induced retinal pericyte apoptosis via inhibition of NF-kappaB activation in vitro and in vivo (Q34391717) (← links)
- Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study (Q34507243) (← links)
- Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults (Q35173430) (← links)
- Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man. (Q35237455) (← links)
- Litsea japonica extract inhibits neuronal apoptosis and the accumulation of advanced glycation end products in the diabetic mouse retina (Q35628566) (← links)
- Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults (Q35690158) (← links)
- RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study (Q35888805) (← links)
- Role of advanced glycation end products in cardiovascular disease. (Q35929112) (← links)
- Glycation products as markers and predictors of the progression of diabetic complications (Q36203971) (← links)
- Low-molecular weight advanced glycation end products: markers of tissue AGE accumulation and more? (Q36203996) (← links)
- Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes? (Q36204022) (← links)
- Relationship of a dominant advanced glycation end product, serum carboxymethyl-lysine, and abnormal glucose metabolism in adults: The baltimore longitudinal study of aging (Q36212513) (← links)
- AGE restriction in diabetes mellitus: a paradigm shift (Q37003623) (← links)
- N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status. (Q37036184) (← links)
- The Extract of Aster Koraiensis Prevents Retinal Pericyte Apoptosis in Diabetic Rats and Its Active Compound, Chlorogenic Acid Inhibits AGE Formation and AGE/RAGE Interaction (Q37285945) (← links)
- Decreased circulatory response to hypovolemic stress in young women with type 1 diabetes. (Q37331346) (← links)
- DNA Advanced Glycation End Products (DNA-AGEs) Are Elevated in Urine and Tissue in an Animal Model of Type 2 Diabetes. (Q37694160) (← links)
- Advanced glycation end products, oxidative stress and diabetic nephropathy (Q37780646) (← links)
- Naturally occurring inhibitors against the formation of advanced glycation end-products (Q37903708) (← links)
- Therapeutic potential of targeting lipid aldehydes and lipoxidation end-products in the treatment of ocular disease. (Q38077549) (← links)
- Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN) (Q38698725) (← links)
- Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions (Q38837915) (← links)
- Cell hypertrophy and MEK/ERK phosphorylation are regulated by glyceraldehyde-derived AGEs in cardiomyocyte H9c2 cells (Q39216600) (← links)
- Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs (Q39436295) (← links)
- Below the radar: advanced glycation end products that detour "around the side". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes? (Q40802125) (← links)
- Glyceraldehyde-Derived Advanced Glycation End Products Accumulate Faster Than Nε-(Carboxymethyl) Lysine. (Q40955558) (← links)
- Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation (Q41227936) (← links)
- Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy (Q41789363) (← links)
- Update on Mechanisms of Renal Tubule Injury Caused by Advanced Glycation End Products (Q41833272) (← links)
- Clinical efficacy of 'Spleen-kidney-care' Yiqi Huayu and Jiangzhuo traditional Chinese medicine for the treatment of patients with diabetic nephropathy (Q42434700) (← links)
- High-density lipoprotein impedes glycation of low-density lipoprotein (Q44036673) (← links)
- Neurotoxicity of acetaldehyde-derived advanced glycation end products for cultured cortical neurons (Q44455399) (← links)
- Low-density lipoprotein levels are one of the independent determinants of circulating levels of advanced glycation end products in nondiabetic subjects. (Q45915232) (← links)
- Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients. (Q46032762) (← links)
- Evaluation of N (epsilon)-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy (Q46470193) (← links)
- Plasma low-molecular weight fluorescence in type 1 diabetes mellitus. (Q46613203) (← links)
- Aster koraiensis extract prevents diabetes-induced retinal vascular dysfunction in spontaneously diabetic Torii rats (Q47159091) (← links)
- Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis. (Q47346953) (← links)
- A Study of Microalbuminuria (MAU) and Advanced Glycation End Products (AGEs) Levels in Diabetic and Hypertensive Subjects (Q49679345) (← links)
- Advanced glycation end products (AGEs) increase human mesangial foam cell formation by increasing Golgi SCAP glycosylation in vitro (Q50539356) (← links)
- Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects (Q51553376) (← links)
- Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes (Q51742202) (← links)